0

544759

GLPL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Goldline Pharmaceutical Ltd Share Price Today

Investment Returns

Over 1 Month -22.14% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Goldline Pharmaceutical Ltd fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 41.80
  • P/E Ratio (TTM) 0.00
  • Beta -1.67
  • Book Value / share 20.99
  • Return on equity 38.74%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Goldline Pharmaceutical Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 28.06
Operating Expense 24.18
Net Profit 2.83
Net Profit Margin (%) 10.08
Earnings Per Share (EPS) 4.11
EBITDA 5.83
Effective Tax Rate (%) 26.42
Particulars MAR 2024 (Values in Cr)
Revenue 23.57
Operating Expense 21.04
Net Profit 1.81
Net Profit Margin (%) 7.67
Earnings Per Share (EPS) 3.01
EBITDA 4.30
Effective Tax Rate (%) 28.45
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.39
ROE % 38.74
ROCE % 27.58
Total Debt to Total Equity 1.22
EBITDA Margin 21.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.34
ROE % 35.70
ROCE % 22.26
Total Debt to Total Equity 1.60
EBITDA Margin 18.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.42
ROE % 9.56
ROCE % 12.82
Total Debt to Total Equity 1.84
EBITDA Margin 12.14
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 26.28
Total Liabilities 26.28
Total Equity 10.35
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 10.78
Return on Capital (%) 13.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 22.93
Total Liabilities 22.93
Total Equity 7.86
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.87
Return on Capital (%) 9.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 19.38
Total Liabilities 19.38
Total Equity 5.89
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.32
Return on Capital (%) 1.53
Particulars MAR 2025 (Values in Cr)
Net Income 3.85
Cash from Operations 3.23
Cash from Investing 0.16
Cash from Financing -2.03
Net change in Cash 0.44
Free Cash Flow 3.44
Particulars MAR 2024 (Values in Cr)
Net Income 2.52
Cash from Operations 3.11
Cash from Investing -1.10
Cash from Financing -1.07
Net change in Cash 0.73
Free Cash Flow 4.22
Particulars MAR 2023 (Values in Cr)
Net Income 0.40
Cash from Operations 2.42
Cash from Investing -1.03
Cash from Financing -1.44
Net change in Cash -0.08
Free Cash Flow 3.53
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 14.15 1.65 262.39 23.12 38.85
BLISS GVS PHARMA LTD 419.15 33.91 3.71 4434.14 118.35 462.70
CIPLA LTD 1388.25 29.46 3.25 112149.13 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.00 15.04 2.46 1003.60 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2183.50 36.23 16.31 36989.81 2136.05 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 23.94 4.41 262.39 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 554.85 24.87 4.33 1604.11 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8383.40 109.49 24.01 20958.50 7630.00 10653.05
BLISS GVS PHARMA LTD 419.15 45.07 3.83 4434.14 118.35 462.70

Goldline Pharmaceutical Ltd shareholding pattern

Holding
29.73%
57.29%
5.15%
7.81%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Goldline Pharmaceutical Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
43.50 -1.58 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 44.50
  • 26 Days 47.20
  • 10 Days 46.00
  • 50 Days 47.20
  • 12 Days 46.80
  • 100 Days 47.20
  • 20 Days 47.20
  • 200 Days 47.20
44.15 PIVOT
First Support 43.31 First Resistance 45.05 Second Support 42.41 Second Resistance 45.89 Third Support 41.57 Third Resistance 46.79
RSI 25.95 ADX 52.88 MACD -0.42 Williams % R -86.62 Commodity Channel Index (CCI) -88.60
Date 2026-06-08 Week 156000.00 Same Day 57000.00 Month 246000.00
1 Year -1.67 3 Year -1.43
Over 1 Month
-22.14% down
Over 1 Year
0.00% down
Over 3 Months
0.00% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

Goldline Pharmaceutical Ltd Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Goldline Pharmaceutical Ltd?

Answer Field

Goldline Pharmaceutical Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 43.50 as on Jun 09 2026 01:49 PM.

What is the Market Cap of Goldline Pharmaceutical Ltd Share?

Answer Field

The market cap of Goldline Pharmaceutical Ltd for NSE ₹ 0.00 & for BSE ₹ 41.80 as on Jun 09 2026 01:49 PM.

What is the 52 Week High and Low of Goldline Pharmaceutical Ltd?

Answer Field

The 52 Week High and Low of Goldline Pharmaceutical Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 60.00 and ₹ 41.76.

What is 1 year return for Goldline Pharmaceutical Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Goldline Pharmaceutical Ltd Share?

Answer Field

As on Jun 09 2026 01:49 PM the price-to-earnings (PE) ratio for Goldline Pharmaceutical Ltd share is 0.00.

What is the PB ratio of Goldline Pharmaceutical Ltd Share?

Answer Field

As on Jun 09 2026 01:49 PM, the price-to-book (PB) ratio for Goldline Pharmaceutical Ltd share is 20.99.

How to Buy Goldline Pharmaceutical Ltd Share?

Answer Field

You can trade in Goldline Pharmaceutical Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Goldline Pharmaceutical Ltd Share on Bajaj Broking App?

Answer Field

To buy Goldline Pharmaceutical Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Goldline Pharmaceutical Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|